Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
GBT Announces Participation at the Cowen and Company 39th Annual Health Care Conference
-
Cowen Stays Positive on Global Blood Therapeutics (GBT), Still Sees Nearly 100% Upside
-
GBT Announces Participation at Upcoming Investor Conferences in March
-
Cowen Reiterates Outperform on Global Blood Therapeutics (GBT) After Meeting with Management
-
Global Blood Therapeutics Announces Participation at Two Upcoming Investor Conferences in March
-
Pre-Open Stock Movers 02/22: (SRRA) (GRMN) (TOL) Higher; (ARGS) (SREV) (TXRH) Lower (more...)
-
Global Blood Therapeutics (GBT) Declines; Doctors on Cowen Panel Said Skeptical on GBT440 Mechanism - Bloomberg
-
Global Blood Therapeutics Announces Closing of Public Offering of Common Stock
-
Global Blood Therapeutics (GBT) Prices 6.4M Common Stock Offering at $18.75/Share
-
Global Blood Therapeutics Announces Pricing of Public Offering of Common Stock
-
Global Blood Therapeutics (GBT) to Offer $100M in Common Stock
-
Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
-
Global Blood Therapeutics (GBT) Data 'Exceeded Our High Expectations' - Cowen
-
Global Blood Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
-
Cowen Starts Global Blood Therapeutics (GBT) at Outperform
-
Global Blood Therapeutics Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option
-
Streetinsider.com's Hot Lunchtime Reads 8/12: (W) (TSLA) (AMGN) (BA)
-
Global Blood Therapeutics (GBT) IPO Opened Up 73%
-
Global Blood Therapeutics (GBT) IPO Set to Open Shortly After Pricing at $20

